Royalty Pharma Pays $3.3B For Cystic Fibrosis Drug Royalties
Private equity pharmaceutical investment firm Royalty Pharma Inc. will pay $3.3 billion in cash to buy royalties on Vertex Pharmaceuticals Inc.'s cystic fibrosis treatments as it continues to expand its drug...To view the full article, register now.
Already a subscriber? Click here to view full article